The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Next Generation Sequencing (NGS) to reveal mutations in IDH1 and its effect on patient (pt) outcomes in advanced biliary tract cancer (aBTC) who received gemcitabine and cisplatin (GC).
 
Daniel H. Ahn
Consulting or Advisory Role - Celltrion (I)
 
Chul Ahn
Honoraria - Celltrion
Consulting or Advisory Role - Macrogen
Travel, Accommodations, Expenses - Macrogen
 
Apurva Jain
No Relationships to Disclose
 
Sameh Mikhail
No Relationships to Disclose
 
Christina Sing-Ying Wu
Consulting or Advisory Role - Bayer
Research Funding - Amgen
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Immunocare Therapies; kanghong Pharma; Lilly; Momenta Pharmaceuticals; Novo Nordisk; Sanofi
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Baxter; Merck KGaA; Sanofi
 
Kristen Keon Ciombor
Research Funding - Boston Biomedical; MedImmune; Pfizer
 
Anne M. Noonan
No Relationships to Disclose
 
Priyanka Sadavartia
No Relationships to Disclose
 
Rachna T. Shroff
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Celgene; Clovis Oncology
Research Funding - Celgene; Lilly
Travel, Accommodations, Expenses - Celgene; Clovis Oncology
 
Milind M. Javle
No Relationships to Disclose
 
James Lin Chen
Consulting or Advisory Role - Ashion Advanced Individual Medicine; Novartis
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; NCCN; Pfizer; Regeneron; Research to Practice; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Polaris